Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Takepron Intravenous 30 mg Drug-Use Survey (Hemostatic Effect/Rebleeding Rate)
jRCT1080222498
- Sponsor
- Takeda
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lansoprazole in gastric ulcer, duodenal ulcer, Acute Stress Gastritis and 1 more, sponsored by Takeda. Primary endpoints: Hemostatic effect and Rebleeding rate.
02
Drugs
lansoprazole
03
Conditions
gastric ulcerduodenal ulcerAcute Stress Gastritisacute gastric mucosal injury (AGMI)
Beyond the preview
Go deeper on jRCT1080222498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222498.